ANSYS Balance Sheet Health
Financial Health criteria checks 5/6
ANSYS has a total shareholder equity of $5.8B and total debt of $754.1M, which brings its debt-to-equity ratio to 12.9%. Its total assets and total liabilities are $7.6B and $1.8B respectively. ANSYS's EBIT is $695.3M making its interest coverage ratio 120.3. It has cash and short-term investments of $1.3B.
Key information
12.9%
Debt to equity ratio
US$754.13m
Debt
| Interest coverage ratio | 120.3x |
| Cash | US$1.30b |
| Equity | US$5.83b |
| Total liabilities | US$1.78b |
| Total assets | US$7.61b |
Recent financial health updates
Is ANSYS (NASDAQ:ANSS) Using Too Much Debt?
Oct 25
Does ANSYS (NASDAQ:ANSS) Have A Healthy Balance Sheet?
May 24Recent updates
Is ANSYS (NASDAQ:ANSS) Using Too Much Debt?
Oct 25A Look At The Fair Value Of ANSYS, Inc. (NASDAQ:ANSS)
Aug 13Here's What's Concerning About ANSYS' (NASDAQ:ANSS) Returns On Capital
Jul 11ANSYS: Navigating Opportunities And Challenges Amidst New Market Dynamics
Jul 08ANSYS, Inc.'s (NASDAQ:ANSS) Earnings Haven't Escaped The Attention Of Investors
Jun 25Does ANSYS (NASDAQ:ANSS) Have A Healthy Balance Sheet?
May 24ANSYS: Rating Upgrade After Merger Confirmation
Apr 05Some Investors May Be Worried About ANSYS' (NASDAQ:ANSS) Returns On Capital
Mar 15Synopsys Is Buying A Great Business, But It Is Paying A Steep Price For ANSYS
Jan 17Investors Still Waiting For A Pull Back In ANSYS, Inc. (NASDAQ:ANSS)
Dec 29Financial Position Analysis
Short Term Liabilities: ANSS's short term assets ($2.3B) exceed its short term liabilities ($754.5M).
Long Term Liabilities: ANSS's short term assets ($2.3B) exceed its long term liabilities ($1.0B).
Debt to Equity History and Analysis
Debt Level: ANSS has more cash than its total debt.
Reducing Debt: ANSS's debt to equity ratio has increased from 0% to 12.9% over the past 5 years.
Debt Coverage: ANSS's debt is well covered by operating cash flow (102.2%).
Interest Coverage: ANSS's interest payments on its debt are well covered by EBIT (120.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 08:06 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ANSYS, Inc. is covered by 45 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Vruwink | Baird |
| Ishan Majumdar | Baptista Research |
| Saket Kalia | Barclays |